EGRX - Eagle Pharmaceuticals Non-GAAP EPS of $3.41 misses by $0.25 revenue of $115.9M misses by $7.53M May, 09 2022 06:52 AM Eagle Pharmaceuticals Inc. Eagle Pharmaceuticals press release (NASDAQ:EGRX): Q1 Non-GAAP EPS of $3.41 misses by $0.25. Revenue of $115.9M (+181.0% Y/Y) misses by $7.53M. For further details see: Eagle Pharmaceuticals Non-GAAP EPS of $3.41 misses by $0.25, revenue of $115.9M misses by $7.53M